Navigation Links
A salty tale: New bacterial genome sequenced from ancient salterns

Tourists in Spain often stop to ogle the country's many saltwater lagoons, used to produce salt since Roman times. Scientists, too, admire these saltern crystallizers--and even more so, the microbes that manage to survive in such briny environs. Now, reporting in the November 28-December 2 early online edition of the Proceedings of the National Academy of Sciences, researchers at The Institute for Genomic Research and collaborators reveal the genome of one bacterium at home in the salty Spanish ponds.

The bacterium is Salinibacter ruber, a bright red, rod-shaped organism. Several years ago, scientists first isolated S. ruber from saltern crystallizer ponds in Alicante and Mallorca, Spain. Although extreme-loving microbes called archaea were known to eke out life in the ponds, scientists were surprised to discover ordinary bacteria also thriving in such a physically demanding environment, at salt concentrations up to 30 percent. How could these microbes--which normally prefer milder environments--thrive in such high salt?

To find out, TIGR researchers Emmanuel Mongodin and Karen Nelson, working with Canadian and Spanish colleagues, set out to sequence S. ruber's genome. In doing so, the scientists discovered evidence that the resourceful bacterium independently evolved some salt-surviving biochemistry. More surprising, S. ruber apparently also borrowed some genes from neighboring archaeal species, in an unusual example of cross-domain lateral gene transfer.

"Scientists are increasingly learning how microbes adapt to harsh environments," remarks Mongodin, first author on the PNAS study, funded by a grant from the National Science Foundation and United States Department of Agriculture. "S. ruber illustrates that even in a really extreme environment, bacteria can do what it takes to survive, including exchanging genes with other microbial species that we might not expect."

Normally, high-salt environments denature bacterial proteins. To
'"/>

Source:The Institute for Genomic Research


Page: 1 2

Related biology news :

1. Microcapsules like it hot and salty
2. Like salty food? Chances are you had low blood sodium when you were born
3. The nude mouse tale: Omega-3 fats save the life of a terminal cancer patient
4. Anti-bacterial additive widespread in U.S. waterways
5. A bacterial genome reveals new targets to combat infectious disease
6. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
7. Scientists discover that host cell lipids facilitate bacterial movement
8. Protein prevents detrimental immune effects of bacterial sepsis
9. Researchers develop new method for facile identification of proteins in bacterial cells
10. A virus-like hitchhiker may trigger bacterial meningitis
11. Using the genomic shortcut to predict bacterial behavior

Post Your Comments:
(Date:11/23/2009)... , CINCINNATINew research presents strong evidenc...sure to both outdoor traffic-related pollution and...ungs than one or the other exposure alone. , E...f Cincinnati (UC) College of Medicine have shown t...c-related particles and indoor endotoxin during ea...
(Date:11/23/2009)... , TORONTO, November 23, 2009 - The time of day...ording to a new paper produced by a research team ...oronto Scarborough,s vice-principal for research a...s biology at the St. George campus. , Capitali...f the poplar tree, the research team examined how ...
(Date:11/23/2009)... , Farmington, CT Current research suggests that... disease. The related report by Nichols et al, "U...nt a New Class of TLR2 Ligands Capable of Enhancin...e of The American Journal of Pathology . , Mult...stem attacks the brain and spinal cord, affects ne...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 1Diabetes drug kills cancer stem cells in combination treatment in mice 9909 2Diabetes drug kills cancer stem cells in combination treatment in mice 9909 3Alert status area in brain discoved by Hebrew University scientists 9907 1Alert status area in brain discoved by Hebrew University scientists 9907 2Translational Research 3A From Bench to Bedside Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 57026 1Translational Research 3A From Bench to Bedside Capitol Hill Breakfast Briefing Hosted by the Council for American Medical Innovation 57026 2
...oth pass on "traditions" to other members of their...ng behaviour. The findings add to evidence that cu...e study involved killerwhales at Marineland in Nia...evised a brand new way to catch birds, and passed ...orca lures gulls into his tank by spitting regurgi...
...ribed to patients with the common cold because the...nd the benefits do not outweigh the risks, accordi... , "Antibiotics appear to have no benefit in the t...ns," conclude Dr. Bruce Arroll and Dr. Timothy Ken...The implications for practice are that prescriptio...
...ands of biologists around the globe run DNA sequen...nline algorithm called BLAST ?typically submitting...de, to be matched against the billions of letters ...an shed light on functional or evolutionary relati...hrough and produce vast amounts of data. Everyday ...
Other Biology News:More animals join the learning circle 2Doctors should stop prescribing antibiotics for the common cold, review advises 2Drawing with DNA: 'Bioart' illuminates genomics 2Drawing with DNA: 'Bioart' illuminates genomics 3
(Date:11/24/2009)..., ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-...ttheNASDAQOMXconferenceonTuesday,December1stat1:45...tenvialiveaudiobroadcastovertheInternetavailableat...Userscanclickthe"Webcast"icontoaccessthisfile. ,...ifeScienceandHighTechnologycompany.Itschemicalandb...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/-...ompanyfocusedondevelopingandcommercializingnovelpa...onno,PresidentandChiefExecutiveOfficer,isscheduled...erence,tobeheldDecember1-2,2009atTheNewYorkPalaceH...higlieri,ChiefFinancialOfficer,willbeavailabletore...
(Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatientsw..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEter...),aglobalbiopharmaceuticalcompanyfocusedonendocrin...datafromaPhase2studywithitstargetedcytotoxicpeptid...advancedorrecurrentendometrialcancer.Inapersonaliz...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCal...dthatRandyScott,GenomicHealth,sExecutiveChairman,w...ferenceinNewYorkCityonTuesday,December1,2009at10:0...vedwebcastofthepresentation,visittheInvestorRelati...or.genomichealth.com .Pleaseconnecttothewebsiteatl...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...armaceuticals, the proprietary products division o...Companies, Inc. (NYSE: PRX ) today,announced that... Inc.,(Amex: IMM ) has chosen to discontinue the ...nvestigative therapy., On February 22, 2008, Immt...rts of adverse events related to abnormal kidney f...
...agene Inc., a,biotechnology company that develops ... announced today that one of the Nature Research,J...he FACTORIAL(TM). In,advance online publication on...colleagues describes a novel and remarkably consis...tivity of a large panel of transcription,factors.,...
...l/ - Oncothyreon Inc. (Nasdaq,- ONTY) (TSX - ONY) ...f,data demonstrating the effectiveness of PX-478 i...8th Annual Targeted Therapies of the Treatment of,...on for the Study of Lung,Cancer in Santa Monica, C...2008, by Jorg J. Jacoby, Ph.D., Instructor, Univer...
Other Biology Technology:Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 2Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine 3Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 2Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 3Oncothyreon's PX-478 is effective in preclinical model of human lung cancer 2Oncothyreon's PX-478 is effective in preclinical model of human lung cancer 3
...0 contains 400 unique human proteins on a 1x3 inch...a cross section of all cellular proteins, are arra...itional control proteins and a specific chip layou...NIchip protein microarrays are high-density protei...
...0 contains 400 unique human proteins on a 1x3 inch...all extracellular proteins (EP) according to Gene ...ate for high-quality results. Additional control p...validity and reproducibility., UNIchip protein mic...
...s are E.Coli glycerol stocks contained in standard...cDNA clones with approximately 5,000 clones per pl... plate well, the corresponding subplate is screene...ve well(s). Cells from a positive well are then pl...
...ed Reticulocyte Lysate Systems(a,b,c,d) offer rese...nslations: a single-tube, coupled transcription/tr...implify the process and reduce the time required t...bbit reticulocyte lysate translations (1) commonly...
Biology Products: